1739 related articles for article (PubMed ID: 15344567)
1. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma. Pathogenesis and multicentricity].
Blum HE; Hopt UT
Chirurg; 2003 Aug; 74(8):709-16. PubMed ID: 12928791
[TBL] [Abstract][Full Text] [Related]
6. Molecular therapy and prevention of hepatocellular carcinoma.
Blum HE
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
8. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
9. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
12. [Molecular aspects of hepatocellular carcinoma].
Moradpour D; Blum HE
Zentralbl Chir; 2000; 125(7):592-6. PubMed ID: 10960967
[TBL] [Abstract][Full Text] [Related]
13. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
Kasai Y; Takeda S; Takagi H
Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
16. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
